USPTO serial 99172601
PREPQUANT
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- GAGNER, NICHOLAS M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).
Need help with PREPQUANT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
San Diego, CA, US
San Diego, CA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Sarah W. Matthews
Sarah W. Matthews Dentons DJP1557 W Innovation Way, Suite 400Lehi, UT 84043United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Reagents for scientific and research use; Diagnostic reagents and preparations for scientific use; Chemical and biotechnological preparations for commercial and scientific research purposes, namely, buffer solutions for use in biological analysis, enzymes for use in scientific and research purposes and enzyme stabilizers, molecular probes in the nature of oligonucleotide probes for research use, DNA and RNA polymerases in the nature of research enzymes, nucleic acids for laboratory, research and scientific purposes, nucleic acid derivatives in the nature of synthetic oligonucleotides for research use, and primers in the nature of oligonucleotide primers for use in polymerase chain reaction (PCR) testing, DNA templates, RNA templates, fluorescent dyes, for laboratory use; biotechnology reagents and solvents for sample preparation, extraction, enrichment, quantification, purification, lysis, modification, and manipulation of cells, namely, lysis buffers, wash buffers, elution buffers, binding buffers, precipitation reagents, and chaotropic salts all for scientific or medical research; Chemical, biochemical, and biotechnological preparations for industrial and scientific purposes in the nature of diagnostic preparations for scientific use; Reagents and chemical solvents in the nature of reagents for medical research and reagents for scientific and research use for the preparation of samples, the modification and manipulation of samples and for performing marking, separation, isolation, purification, quantification, reproduction, and analysis methods for biopolymers, namely, nucleic acids, proteins, macromolecules, and biologically active substances; Kits comprising chemical preparations for scientific purposes for the preparation of samples, for the modification and manipulation of samples, and for the marking, separation, isolation, purification, quantification, reproduction, and analysis of biopolymers, namely, nucleic acids, proteins, macromolecules, and biologically active substances in the nature of nucleic acids from biological and biochemical sample material; Nucleic acid, and proteinaceous being biological reagents and biochemical reagents used for non-medical or veterinary research, namely laboratory, research and scientific purposes, specifically, for use with transcription systems, sequencing systems, detection, purification, and quantification systems, translation in vitro systems, genomic cloning/mapping systems, protein analysis products, expression systems, and reagent-based biochemical systems for use in forensics; Reagents, enzymes, and nucleotides for non-medical or veterinary genetic research; Biological chemical agents being biological preparations for use in laboratories for scientific and research use; Laboratory instruments, namely, nucleic acid sequencers for use in genetic research for laboratory, research and scientific use | ACTIVE | — |
| 005 | Biological and biochemical reagents, namely, diagnostic reagents, for clinical medical, medical therapeutic, and medical use; Reagents for medical use; Medical diagnostic reagents; Diagnostic test reagents for medical use; Biological reagents for medical use; Chemical reagents for medical use; Diagnostic preparations for medical use, namely, buffer solutions in the nature of lysis buffers, wash buffers, and elution buffers for medical purposes, enzymes for medical purposes, molecular probes in the nature of oligonucleotide probes for medical purposes, DNA and RNA polymerases in the nature of medical diagnostic enzymes for medical use, nucleic acids for medical or veterinary purposes, nucleic acid derivatives in the nature of synthetic oligonucleotides for medical purposes, and, primers in the nature of oligonucloetide primers for use in polymerase chain reaction (PCR) testing for medical purposes; DNA templates and RNA templates for medical purposes; dyes for medical diagnostic use; biotechnology reagents and solvents for sample preparation, purification, quantification, lysis, modification, and manipulation of cells for medical purposes; Medical diagnostic preparations for medical use, namely, for the treatment, monitoring, and diagnosis of disease; diagnostic preparations for clinical and medical use; Medical diagnostic assays for testing biological samples in the nature of body fluids and tissue samples for the treatment and diagnosis of disease; Diagnostic assays for testing biological samples in the nature of body fluids and tissue samples for clinical and medical use; Diagnostic preparations for medical purposes, namely, for the preparation of samples, for the modification and manipulation of samples, and for the marking, separation, isolation, purification, quantification, and reproduction and analysis of biopolymers, namely, nucleic acids, proteins, macromolecules, and biologically active substances; Chemical, biochemical, and biotechnological preparations for medical purposes, namely, reagents and solvents in the nature of extraction, purification, quantification and amplification reagents for medical use for the preparation of samples, for the modification and the manipulation of samples, and for performing marking, separation, isolation, purification, reproduction, and analysis methods for biopolymers, namely, nucleic acids, proteins, macromolecules, and biologically active substances for diagnostic, medical, clinical, or therapeutic purposes; Kits comprising diagnostic preparations for medical and veterinary medical diagnostic, clinical, and therapeutic purposes for the preparation of samples, for the modification and manipulation of samples, and for marking, separation, isolation, purification, quantification, reproduction, and analysis of biopolymers, namely, nucleic acids, proteins, macromolecules, and biologically active substances in the nature of nucleic acids from biological or biochemical sample material; Diagnostic preparations for medical use; In vitro diagnostic agents for medical use; Biochemicals in the nature of chemical reagents for the purification and quantification of nucleic acids for medical use; nucleic acids for medical use; Biochemical reagents used for medical use, specifically, for use with transcription systems, sequencing systems, detection, purification, and quantification systems, translation in vitro systems, genomic cloning/mapping systems, protein analysis products, expression systems, and reagent-based biochemical systems for use in forensics | ACTIVE | — |
| 009 | Medical laboratory research instruments for isolating, enriching, and quantifying nucleic acids from samples; Scientific apparatus and instruments for research use, namely, instruments for use in isolating, enriching, and quantifying nucleic acid from samples in the laboratory and parts and fittings therefor; Downloadable computer software for use in database management to integrate data and information, as well as provide access to real-time financial information for use by companies, including foreign companies; Downloadable computer software for managing business and laboratory data relating to sales, sales management, business management, project management, sample control, sample scheduling, quality control, report management, and invoicing; Downloadable computer software for tracking the location of clinical samples; Laboratory equipment, measuring apparatus, and instruments, namely, scientific laboratory instruments for research use for the preparation, modification, and manipulation of biological samples, and for the marking, separation, isolation, purification, quantification, reproduction and analysis of biopolymers, namely nucleic acids, proteins, macromolecules, and biologically active substances in the nature of nucleic acids from biological or biochemical sample material; Scientific laboratory instruments for research use for testing, processing, and detecting biological samples; Downloadable computer software for analyzing and managing biological data; Laboratory instruments, namely, nucleic acid sequencers for scientific purposes for use in genetic research; Apparatus in the nature of cartridges sold prefilled with reagents for the purification of nucleic acids for scientific use; Apparatus in the nature of extraction, purification, quantification and amplification cartridges, including magnetic bead-based systems, for the pre-analytical processing of nucleic acids with reagents, cells, nucleic acids and proteins for scientific use | ACTIVE | — |
| 010 | Cartridges sold empty in the nature of medical sample cartridges in the nature of medical sample containers and medical sample containers for the extraction, quantification, enrichment, and purification of nucleic acids for medical use, and parts and fittings therefor in the nature of lids and fittings for medical sample cartridges and medical sample containers; Medical apparatus in the nature of sample preparation devices for medical diagnostic uses including cartridges pre-filled with reagents, for the pre-analytical and analytical processing of nucleic acids, cells and proteins with reagents for medical use | ACTIVE | — |
| 042 | Providing medical testing in the field of biological research and disease for research purposes and consultation related thereto; Scientific laboratory services, namely, performing the isolation, detection, quantification, and analysis of biological substances from clinical samples for others; Scientific research in the nature of conducting clinical trials for others for the diagnosis, monitoring, and treatment of disease; Scientific and technological research services, namely, scientific research, analysis, and testing in the fields of chemistry, genetics, biology, and biochemistry, and scientific development in the fields of chemistry, genetics, biology, and biochemistry; Providing reagent sample diagnostic services for others for scientific research purposes in the fields of DNA, RNA, and protein detection and analysis; New product design for others in the fields of chemistry, genetics, biology, and biochemistry | ACTIVE | — |
| 044 | Providing medical testing and consultation related thereto; Medical diagnostic services in the fields of DNA, RNA, and protein detection and analysis | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by INVIVOSCRIBE, INC.
- Other trademarks owned by INVIVOSCRIBE, INC.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named PREPQUANT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 15, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 15, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 9, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 17, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 14, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 14, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 14, 2026 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| May 11, 2026 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| May 11, 2026 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Feb 23, 2026 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Feb 23, 2026 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 23, 2026 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 22, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 22, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 22, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 1, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 1, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 1, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 23, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 15, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 6, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 6, 2025 | NWAP | NEW APPLICATION ENTERED | — |